Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy
CHICAGO, Sept. 28, 2021 /PRNewswire/ — Novian Health Inc. has been granted Breakthrough Device designation from the U.S. Food and Drug Administration for its Novilase®Interstitial Laser System and its proposed indication for use: the focal destruction of malignant breast tumors in adult…
Comments Off on Novian Health Gains FDA Breakthrough Designation for Novilase Breast Therapy